• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Keratoconus Treatment Companies

    ID: MRFR/HC/2574-CR
    153 Pages
    Kinjoll Dey
    July 2021

    Keratoconus is a progressive eye disorder that results in the thinning and reshaping of the cornea, leading to distorted vision. Treatment options range from eyeglasses and contact lenses to surgical interventions.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Keratoconus Treatment Market Research Report — Global Forecast till 2035 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Keratoconus Treatment Market

    Keratoconus Treatment Key CompaniesLatest Keratoconus Treatment Companies Update



    • October 2023: EpiSmartTM, Epion's minimally invasive keratoconus treatment, has entered Phase 3 Apricity studies, the firm reported. This is a major step forward in the company's efforts to revolutionize the care for keratoconus. EpiSmart is a drug-device combination being studied for the treatment of keratoconus using epithelium-on cross-linking. Recent research suggests that keratoconus, a bilateral progressive corneal condition that can lead to irreversible vision loss, is more common in Africa and the Middle East than in the United States, where an estimated 3 million people suffer from it. Building on the positive results seen in Phase 2 clinical trials, the Apricity studies will assess the safety and effectiveness of EpiSmart through randomization, masking, and placebo control.




    • July 2023: Epion Therapeutics, Inc. is the proud new name for CXL Ophthalmics, Inc., a pioneer in the treatment of corneal diseases. The new name better reflects the company's goal to provide a therapy for keratoconus that is both the safest and least intrusive in the globe. Epion's Phase 3 Trials of the EpiSmartTM System will not begin unless this plan and strategy are in place. The ability to maintain functional eyesight may be preserved with prompt diagnosis and treatment. Epion Therapeutics is at the forefront of early intervention, which aims to treat patients immediately upon diagnosis rather than waiting for the disease to worsen. Through rigorous scientific research, Epion is reinventing the standard of treatment for keratoconus. Epion is developing a technique that will not harm the corneal epithelium in any way (chemically or physically). Recovery time, patient pain, and infection risk may all be reduced using Epion's novel methodology compared to both conventional epi-off and cutting-edge epi-on cross-linking techniques


    List of Keratoconus Treatment Key companies in the market

    • HOYA vision care company,

    • Menicon Co., Ltd.,

    • Cooper companies Inc.,

    • Baush Health,

    • SynergEyes,

    • Carl Zeiss Meditec AG,

    • Contamac,

    • Seed Co., Ltd.,

    • Novartis AG,

    • Johnson & Johnson Services, Inc.